Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% |
|
-.--% | -.--% |
2024 | ThermoGenesis Holdings, Inc. Announces Resignation of Jeffery Cauble as Chief Financial Officer | CI |
2024 | ThermoGenesis Holdings, Inc. Receives A Notice of Default from Boyalife Group, Inc | CI |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 13.05M | 9.74M | 9.29M | 10.48M | 9.44M | |||||
Total Revenues | 13.05M | 9.74M | 9.29M | 10.48M | 9.44M | |||||
Cost of Goods Sold, Total | 7.35M | 8.48M | 5.8M | 7.77M | 7.51M | |||||
Gross Profit | 5.7M | 1.26M | 3.49M | 2.71M | 1.93M | |||||
Selling General & Admin Expenses, Total | 6.73M | 7.82M | 8.93M | 7.67M | 7.22M | |||||
R&D Expenses | 2.3M | 2.34M | 1.79M | 1.24M | 1.28M | |||||
Other Operating Expenses, Total | 9.03M | 10.15M | 10.72M | 8.9M | 8.5M | |||||
Operating Income | -3.33M | -8.9M | -7.23M | -6.19M | -6.57M | |||||
Interest Expense, Total | -4.48M | -7.91M | -6.1M | -5.62M | -10.03M | |||||
Interest And Investment Income | - | - | - | - | - | |||||
Net Interest Expenses | -4.48M | -7.91M | -6.1M | -5.62M | -10.03M | |||||
Income (Loss) On Equity Invest. | -15K | -13K | - | - | - | |||||
Other Non Operating Income (Expenses) | -32K | 5K | 802K | -3K | 49K | |||||
EBT, Excl. Unusual Items | -7.86M | -16.81M | -12.53M | -11.81M | -16.56M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | - | - | - | - | -2.04M | |||||
Legal Settlements | -1.4M | - | - | - | - | |||||
Other Unusual Items | -840K | - | 652K | - | -326K | |||||
EBT, Incl. Unusual Items | -10.1M | -16.81M | -11.88M | -11.81M | -18.92M | |||||
Income Tax Expense | - | - | - | - | - | |||||
Earnings From Continuing Operations | -10.1M | -16.81M | -11.88M | -11.81M | -18.92M | |||||
Net Income to Company | -10.1M | -16.81M | -11.88M | -11.81M | -18.92M | |||||
Minority Interest | 602K | 460K | 501K | 542K | 944K | |||||
Net Income - (IS) | -9.5M | -16.35M | -11.38M | -11.27M | -17.98M | |||||
Net Income to Common Incl Extra Items | -9.5M | -16.35M | -11.38M | -11.27M | -17.98M | |||||
Net Income to Common Excl. Extra Items | -9.5M | -16.35M | -11.38M | -11.27M | -17.98M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -151.09 | -117.2 | -43.41 | -20.45 | -7.59 | |||||
Basic EPS - Continuing Operations | -151.09 | -117.2 | -43.41 | -20.45 | -7.59 | |||||
Basic Weighted Average Shares Outstanding | 62.86K | 140K | 262K | 551K | 2.37M | |||||
Net EPS - Diluted | -151.09 | -117.2 | -43.41 | -20.45 | -7.59 | |||||
Diluted EPS - Continuing Operations | -151.09 | -117.2 | -43.41 | -20.45 | -7.59 | |||||
Diluted Weighted Average Shares Outstanding | 62.86K | 140K | 262K | 551K | 2.37M | |||||
Normalized Basic EPS | -68.57 | -72.01 | -27.97 | -12.41 | -3.97 | |||||
Normalized Diluted EPS | -68.57 | -72.01 | -27.97 | -12.41 | -3.97 | |||||
Supplemental Items | ||||||||||
EBITDA | -2.64M | -8.28M | -6.6M | -5.27M | -5.43M | |||||
EBITA | -3.21M | -8.79M | -7.19M | -6.16M | -6.54M | |||||
EBIT | -3.33M | -8.9M | -7.23M | -6.19M | -6.57M | |||||
EBITDAR | -2.54M | -8.14M | -6.18M | -4.84M | - | |||||
Total Revenues (As Reported) | 13.05M | 9.74M | - | - | - | |||||
Effective Tax Rate - (Ratio) | - | - | - | - | - | |||||
Deferred Domestic Taxes | - | - | - | - | - | |||||
Deferred Foreign Taxes | - | - | - | - | - | |||||
Total Deferred Taxes | - | - | - | - | - | |||||
Normalized Net Income | -4.31M | -10.05M | -7.33M | -6.84M | -9.4M | |||||
Interest on Long-Term Debt | 4.85M | 5.2M | 5.54M | 4.9M | 9.15M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 1.66M | 1.95M | - | - | - | |||||
General and Administrative Expenses | 4.98M | 5.73M | - | - | - | |||||
Research And Development Expense From Footnotes | 2.4M | 2.48M | 2.21M | 1.66M | 1.28M | |||||
Net Rental Expense, Total | 98K | 139K | 416K | 422K | - | |||||
Imputed Operating Lease Interest Expense | 1.01M | 1.29M | 2.2M | 1.75M | - | |||||
Imputed Operating Lease Depreciation | -908K | -1.15M | -1.78M | -1.32M | - | |||||
Stock-Based Comp., COGS (Total) | 3K | 9K | 17K | 18K | 17K | |||||
Stock-Based Comp., R&D Exp. (Total) | 98K | 114K | 268K | 20K | 22K | |||||
Stock-Based Comp., S&M Exp. (Total) | 185K | 176K | - | - | - | |||||
Stock-Based Comp., G&A Exp. (Total) | 328K | 581K | - | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | 2.28M | 229K | - | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 614K | 880K | 2.56M | 267K | 39K |
- Stock Market
- Equities
- THMO Stock
- Financials ThermoGenesis Holdings, Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions